New Option for the Initial Management of Metastatic Pancreatic Cancer?

Journal of Clinical Oncology - United States
doi 10.1200/jco.2013.54.4155
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society of Clinical Oncology (ASCO)

Related search

Ixabepilone: A New Treatment Option for the Management of Taxane-Resistant Metastatic Breast Cancer

Cancer Management and Research
Oncology
2009English

Stereotactic Body Radiation Therapy: A New Standard Option for Pancreatic Cancer?

Journal of the National Comprehensive Cancer Network : JNCCN
MedicineOncology
2014English

Pancreatic Cancer: Planning Ahead for Metastatic Spread

Cancer Cell
Cancer ResearchOncologyCell Biology
2016English

Bridging Clinic: The Initial Medical Management of Patients With Newly Diagnosed Pancreatic Cancer

Frontline Gastroenterology
HepatologyGastroenterology
2018English

Cross-Over Comparison and New Chemotherapy Regimens in Metastatic Pancreatic Cancer

Memo - Magazine of European Medical Oncology
OncologyHematology
2017English

Fulvestrant: A Further Treatment Option for Patients With Metastatic Uterine Cancer?

Oncology Research and Treatment
Cancer ResearchOncologyHematology
2006English

Encapsulated Irinotecan Provides Novel Option for Hard-To-Treat Pancreatic Cancer

Journal of Community and Supportive Oncology
OncologyHematology
2016English

Conversion Technologies: A New Option for MSW Management

2005English

Resected Metastatic Pancreatic Cancer 13 Years After Surgery for Ascending Colon Cancer

Japanese Journal of Gastroenterological Surgery
SurgeryGastroenterology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy